Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

2856 – Tramadol Dependence in a Patient with no Previous Substance History

View through CrossRef
Introduction:Tramadol, initially introduced in Germany in 1977, is a synthetic analgesic and appears to have a dual mechanism of action; a weak μ-opioid receptor agonism and a reuptake inhibition of serotonin and noradrenaline. It is marketed in Tunisia since 2001. Generally, Tramadol is considered to have a very low risk of dependence and abuse, but rare cases of tramadol dependence have been described in patients without prior substance abuse history. We describe one such case in a relatively young, otherwise healthy patient.Case report:Mr AR, a 47-year-old man, presented to get help with tramadol addiction. He had no previous history of illicit drug use, did not smoke cigarettes or drank alcohol.Mr AR was started on tramadol treatment about 2 years earlier for back pain. He did have better pain control with tramadol, but he gradually started taking more and more. Ultimately, his pain resolved but he was unable to stop taking tramadol: he was taking up to 1700 mg/d of tramadol and had made multiple efforts to stop. When he stopped taking tramadol, he had dysphoria, muscle cramps, anxiousness, restlessness, and a sensation of insects crawling all over his body. His withdrawal symptoms were severe enough to interfere with his work and family life.Conclusion:Tramadol dependence is very rare but can happen in a patient without substance abuse history. We, as medical practitioners, should be open to the possibility of tramadol dependence and should resort to optimal and judicious use of such a substance.
Title: 2856 – Tramadol Dependence in a Patient with no Previous Substance History
Description:
Introduction:Tramadol, initially introduced in Germany in 1977, is a synthetic analgesic and appears to have a dual mechanism of action; a weak μ-opioid receptor agonism and a reuptake inhibition of serotonin and noradrenaline.
It is marketed in Tunisia since 2001.
Generally, Tramadol is considered to have a very low risk of dependence and abuse, but rare cases of tramadol dependence have been described in patients without prior substance abuse history.
We describe one such case in a relatively young, otherwise healthy patient.
Case report:Mr AR, a 47-year-old man, presented to get help with tramadol addiction.
He had no previous history of illicit drug use, did not smoke cigarettes or drank alcohol.
Mr AR was started on tramadol treatment about 2 years earlier for back pain.
He did have better pain control with tramadol, but he gradually started taking more and more.
Ultimately, his pain resolved but he was unable to stop taking tramadol: he was taking up to 1700 mg/d of tramadol and had made multiple efforts to stop.
When he stopped taking tramadol, he had dysphoria, muscle cramps, anxiousness, restlessness, and a sensation of insects crawling all over his body.
His withdrawal symptoms were severe enough to interfere with his work and family life.
Conclusion:Tramadol dependence is very rare but can happen in a patient without substance abuse history.
We, as medical practitioners, should be open to the possibility of tramadol dependence and should resort to optimal and judicious use of such a substance.

Related Results

Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis
Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis
AbstractBackground and AimsMisuse of tramadol, an opioid prescription analgesic, is known as a public health challenge globally. We aimed to systematically review studies on the pr...
The prevalence of tramadol use and its dependence for the pain management in Al Ahsa district of Saudi Arabia: A chart review study
The prevalence of tramadol use and its dependence for the pain management in Al Ahsa district of Saudi Arabia: A chart review study
Background: Tramadol hydrochloride, synthetic centrally acting opioid analgesics is being widely used throughout the world. In many Middle East countries, tramadol abuse was raised...
Cognitive Impairment and Tramadol Dependence
Cognitive Impairment and Tramadol Dependence
AbstractBackground and ObjectiveCognitive impairment is one of the consequences of substance abuse. Tramadol abuse is a public health problem in Egypt. The objective of this study ...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Prevalence of Tramadol Abuse and Associated Factors among Hawassa University Students
Prevalence of Tramadol Abuse and Associated Factors among Hawassa University Students
Abstract Introduction:Tramadol abuse is a current public health concern in Ethiopia. Drug abuse including that of tramadol is a significant public health issue that causes ...
Comparative Pharmacology and Toxicology of Tramadol & Tapentadol
Comparative Pharmacology and Toxicology of Tramadol & Tapentadol
Pain is a common symptom in various health conditions and can significantly impact a person's quality of life if not managed properly. Although non-steroidal anti-inflammatory drug...
Tapentadol Versus Tramadol for Preemptive Analgesia in Elective Surgery Under General Anesthesia: A Randomized Controlled Trial
Tapentadol Versus Tramadol for Preemptive Analgesia in Elective Surgery Under General Anesthesia: A Randomized Controlled Trial
Background: Effective control of postoperative pain is a critical component of perioperative care. Tramadol is commonly used for preemptive analgesia but is associated with variabl...

Back to Top